Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,152.64
(
-1.15%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 163220

Thursday, 07/11/2013 10:08:17 AM

Thursday, July 11, 2013 10:08:17 AM

Post# of 257580
FDA accepts Eliquis nNDA for primary VTE prevention following hip/knee surgery; PDUFA date is 3/15/14:

http://finance.yahoo.com/news/fda-accepts-eliquis-apixaban-supplemental-113000798.html

Note: The sNDA in primary VTE prevention is separate from the sNDA in VTE treatment and secondary prevention, which is slated for submission to the FDA during the current quarter (#msg-89518539).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today